Synopsis of recent research by authors named "Xinxin Li"
- Xinxin Li's recent research spans multiple areas, focusing on the development of innovative therapeutic strategies for hematological malignancies, particularly B-cell acute lymphoblastic leukemia (B-ALL), with studies evaluating the role of epigenetic regulators like YTHDC1.
- Research also highlights significant advances in the understanding and treatment of hepatitis B virus (HBV) related hepatocellular carcinoma (HCC), examining immune responses and epigenetic modifications as key factors influencing disease progression and treatment efficacy.
- Additionally, Li has investigated novel biotechnological approaches, such as advanced detection methods for aquatic bacteria and the potential of chimeric endolysins in treating bovine mastitis, emphasizing the need for alternatives to traditional antibiotics due to resistance issues.
